The global women’s health diagnostics market was valued at USD 24.8 billion in 2021 and it is anticipated to grow up to USD 49.0 billion by 2031, at a CAGR of 7.0% during the forecast period.
Screening, testing or diagnosing, and monitoring of various women’s health disorders such as ovarian cancer, breast cancer, menopause, pregnancy and cervical cancer are examples of women’s health diagnostic methods. For the diagnosis of women’s health-related diseases, various types of tests are available including Breast cancer testing, cervical cancer testing, prenatal genetic screening & carrier testing, pregnancy & ovulation testing, and ovarian cancer testing are all part of the diagnostic process. Moreover, imaging & monitoring systems, mammography systems, Biopsy devices, and other medical diagnostics devices that detect cancer, remove blockages, and capture images of internal organs to aid in disease screening and diagnosis. To avoid complications and improve quality of life, tests for screening and detection of various disorders are required. Health tests are essential for maintaining good health as well as preventing and treating serious diseases.
To Remain ‘Ahead’ Of Your Competitors, Request for A Sample –https://www.globalinsightservices.com/request-sample/GIS10385
Market Trends and Drivers
Rising prevalence of chronic and infectious diseases in females is poised to boost the market expansion. Changes in lifestyle and growing consumption of unhealthy food will upsurge the risk of disease. Moreover, lack of awareness regarding sanitation and genital health coupled with unavailability of well-developed healthcare facilities in developing economies will fuel the market growth during the forecast period. Additionally, increasing healthcare expenditure, availability of newer and advanced diagnostic systems and growth in awareness about malignant tumors, are anticipated to propel the industry growth in near future. Furthermore, growing number of product developments and strategic collaboration among the diagnostic device market players and their entry in developing countries provide numerous opportunities for market progression. Conversely, huge untapped market potential in emerging countries such as South Africa and India, as well as the development of novel and advanced imaging procedures such as miniature devices, are expected to provide market participants with lucrative opportunities
Get A Customized Scope to Match Your Need Ask an Expert –https://www.globalinsightservices.com/request-customization/GIS10385
- Diagnostic Devices
- Diagnostic Tests
- Accessories and Consumables
- Breast Cancer
- Infectious Disease Testing
- Osteoporosis Testing
- Pregnancy and Fertility Testing
- Sexually Transmitted Disease Testing
- Other Applications
- Hospitals and Clinics
- Diagnostic and Imaging Centers
Major Players in the Global Women’s Health Diagnostics Market
The key players in the market are Abbott (U.S.), BD (U.S.), Cardinal Health, Inc. (U.S.), F.Hoffmann-La Roche Ltd. (Switzerland), General Electric Company (U.S.), Hologic, Inc. (U.S.), Koninklijke Philips N.V. (Netherland), Quest Diagnostics Incorporated (U.S.), Siemens Medical Solutions USA, Inc. (Germany), and bioMérieux SA. (U.S.).
For In-Depth Competitive Analysis, Purchase this Report –https://www.globalinsightservices.com/checkout/single_user/GIS10385
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.